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Conversion of aspartate aminotransferase into an L-aspartate
beta-decarboxylase by a triple active-site mutation
Abstract
The conjoint substitution of three active-site residues in aspartate aminotransferase (AspAT) of
Escherichia coli (Y225R/R292K/R386A) increases the ratio of L-aspartate beta-decarboxylase activity
to transaminase activity >25 million-fold. This result was achieved by combining an arginine shift
mutation (Y225R/R386A) with a conservative substitution of a substrate-binding residue (R292K). In
the wild-type enzyme, Arg(386) interacts with the alpha-carboxylate group of the substrate and is one of
the four residues that are invariant in all aminotransferases; Tyr(225) is in its vicinity, forming a
hydrogen bond with O-3' of the cofactor; and Arg(292) interacts with the distal carboxylate group of the
substrate. In the triple-mutant enzyme, k(cat)' for beta-decarboxylation of L-aspartate was 0.08 s(-1),
whereas k(cat)' for transamination was decreased to 0.01 s(-1). AspAT was thus converted into an
L-aspartate beta-decarboxylase that catalyzes transamination as a side reaction. The major pathway of
beta-decarboxylation directly produces L-alanine without intermediary formation of pyruvate. The
various single- or double-mutant AspATs corresponding to the triple-mutant enzyme showed, with the
exception of AspAT Y225R/R386A, no measurable or only very low beta-decarboxylase activity. The
arginine shift mutation Y225R/R386A elicits beta-decarboxylase activity, whereas the R292K
substitution suppresses transaminase activity. The reaction specificity of the triple-mutant enzyme is
thus achieved in the same way as that of wild-type pyridoxal 5'-phosphate-dependent enzymes in
general and possibly of many other enzymes, i.e. by accelerating the specific reaction and suppressing
potential side reactions.
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The conjoint substitution of three active-site residues
in aspartate aminotransferase (AspAT) of Escherichia
coli (Y225R/R292K/R386A) increases the ratio of L-aspar-
tate b-decarboxylase activity to transaminase activity
>25 million-fold. This result was achieved by combining
an arginine shift mutation (Y225R/R386A) with a con-
servative substitution of a substrate-binding residue
(R292K). In the wild-type enzyme, Arg386 interacts with
the a-carboxylate group of the substrate and is one of
the four residues that are invariant in all aminotrans-
ferases; Tyr225 is in its vicinity, forming a hydrogen bond
with O-3* of the cofactor; and Arg292 interacts with the
distal carboxylate group of the substrate. In the triple-
mutant enzyme, kcat* for b-decarboxylation of L-aspar-
tate was 0.08 s21, whereas kcat* for transamination was
decreased to 0.01 s21. AspAT was thus converted into an
L-aspartate b-decarboxylase that catalyzes transamina-
tion as a side reaction. The major pathway of b-decar-
boxylation directly produces L-alanine without interme-
diary formation of pyruvate. The various single- or
double-mutant AspATs corresponding to the triple-mu-
tant enzyme showed, with the exception of AspAT
Y225R/R386A, no measurable or only very low b-decar-
boxylase activity. The arginine shift mutation Y225R/
R386A elicits b-decarboxylase activity, whereas the
R292K substitution suppresses transaminase activity.
The reaction specificity of the triple-mutant enzyme is
thus achieved in the same way as that of wild-type pyr-
idoxal 5*-phosphate-dependent enzymes in general and
possibly of many other enzymes, i.e. by accelerating the
specific reaction and suppressing potential side
reactions.
In the engineering of protein catalysts with new functional
properties, the modification of existing enzymes provides an
alternative to the production of catalytic antibodies or, in a
more distant future, the de novo design of enzymes. Enzyme
engineering may be expected to contribute to elucidating both
the structural basis of the functional properties and the course
of the molecular evolution. Several attempts to change the
substrate specificity of an enzyme by substitution of the sub-
strate-binding residues have succeeded (Refs. 1–9; for a review,
see Ref. 6). Among the pyridoxal 59-phosphate-dependent en-
zymes, aspartate aminotransferase (AspAT)1 has been con-
verted by multiple active-site mutations into an L-tyrosine ami-
notransferase (5) and by directed molecular evolution into an
L-branched-chain amino acid aminotransferase (7, 8). Tyrosine
phenol-lyase has been engineered by a double mutation to act
as a dicarboxylic-acid b-lyase (an enzyme not found in nature)
that degrades aspartate to pyruvate, ammonia, and formate
(9). However, as yet, no change in the reaction specificity of an
enzyme has been reported, with the exception of the conversion
of papain into a peptide-nitrile hydratase (10). A change in the
reaction specificity may be claimed if a new catalytic activity
not inherent in the wild-type enzyme is generated and the
original activity of the wild-type enzyme is suppressed to a
level significantly below that of the new activity.
The pyridoxal 59-phosphate (PLP)-dependent enzymes (B6
enzymes) catalyze numerous reactions in the metabolism of
amino acids. The B6 enzymes are of multiple evolutionary
origin and constitute a few families of homologous proteins of
which the a-family is by far the largest (11). The enzyme
members of the a-family, which includes AspAT, not only pos-
sess similar protein scaffolds, but most of them also share the
first two steps of the reaction pathway (for a succinct introduc-
tion into PLP-dependent reaction pathways, see Ref. 12). The
amino group of the incoming substrate replaces the e-amino
group of the active-site lysine residue, the internal aldimine 1
(see Scheme 1), thus being followed by the external aldimine
intermediate 2, which is then deprotonated at C-a to give the
quinonoid intermediate 3. Only in the subsequent step do the
reaction pathways of the different B6 enzymes diverge, leading
to racemization, transamination, b- and g-elimination and re-
placement. It seems therefore feasible to make the quinonoid
intermediate 3 in a given enzyme adopt an alternative reaction
course by substituting few critical active-site residues.
Aspartate aminotransferase is the most extensively studied
B6 enzyme. The homodimeric enzyme (2 3 400 amino acid
residues) catalyzes the reversible transfer of the amino group of
aspartate or glutamate to the cognate oxo acids. A detailed
mechanism of action has been derived from combined biochem-
ical and crystallographic data (13). In a previous study, we
have generated L-aspartate b-decarboxylase activity in AspAT
of Escherichia coli by introducing a double active-site mutation
(14). AspAT Y225R/R386A b-decarboxylated L-aspartate to L-
alanine with kcat9 5 0.08 s
21, i.e. 1330-fold faster than the
wild-type enzyme. However, transaminase activity, despite a
decrease by 3 orders of magnitude, still exceeded b-decarboxy-
lase activity by a factor of 2.5.
Here we searched for a third mutation that, if introduced
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into AspAT Y225R/R386A, would decrease further transami-
nase activity without affecting b-decarboxylase activity. The
only mutation among many tested that brought about this
effect was the replacement of the second active-site arginine
residue, i.e. Arg292 (a residue of the adjacent subunit of the
AspAT homodimer) with lysine. In the wild-type enzyme,
Arg292 binds the distal carboxylate group of the substrate (Fig.
1). The single R292K mutation had been previously found to
decrease transaminase activity to 0.2% of that of the wild-type
enzyme (15). In the triple-mutant enzyme, b-decarboxylase
activity indeed exceeded transaminase activity by a factor of 8.
EXPERIMENTAL PROCEDURES
Oligonucleotide-directed Mutagenesis and Enzyme Purification—Oli-
gonucleotide-directed mutagenesis of the wild-type aspC gene of E. coli
inserted into the BS M13 vector (16) was performed with the mutagen-
esis kit from Bio-Rad. The mutations were confirmed by determination
of the nucleotide sequences. The mutated DNAs were expressed in the
AspAT-deficient E. coli strain TY103 (17) with the expression vector
pKDHE19 (18). Wild-type and mutant enzymes were purified with
previously described chromatographic procedures. Fractions containing
pure AspAT were pooled, concentrated, and reconstituted with coen-
zyme as described (19).
Determination of Protein Concentration and Aminotransferase Activ-
ity—The concentration of the purified enzymes in the PLP form was
determined spectrophotometrically at 280 nm using the molar absorp-
tion coefficient of the subunit, e 5 4.7 3 104 M21 cm21 (20). Kinetic
parameters for aminotransferase activities of AspAT mutants and the
wild-type enzyme were measured in a coupled assay with malate dehy-
drogenase containing 40 mM L-aspartate plus 20 mM 2-oxoglutarate as
substrates for the wild-type enzyme and 100 mM L-aspartate plus 50 mM
2-oxoglutarate for the mutant enzymes. The values of kcat refer to
subunit concentrations. The Km9 values for L-aspartate and 2-oxoglut-
arate were measured at fixed concentrations of 2-oxoglutarate (50 mM)
and L-aspartate (200 mM), respectively.
For measuring the consumption and production of oxo acids, the
enzymes (0.45 mM, subunit concentration) were incubated with 200 mM
L-aspartate and 8 mM oxalacetate in 250 mM 4-methylmorpholine (pH
7.5) at 25 °C. Samples (40 ml) were deproteinized at different time
intervals with 1 M perchloric acid (final concentration) and neutralized
with potassium hydroxide. Oxalacetate and pyruvate were determined
separately by consumption of NADH in the presence of malate dehy-
drogenase and lactate dehydrogenase, respectively. The b-decarboxyla-
tion of oxalacetate in the absence of enzyme (t1⁄2 5 60 min under the
conditions detailed in the legend of Fig. 2 with 0.45 mM PLP added) was
neglected in the calculations of kcat for the different enzyme variants.
Measurement of Rates of b-Decarboxylation and Other Side Reac-
tions—AspATs were incubated with amino acid and their cognate oxo
acid in 250 mM 4-methylmorpholine (pH 7.5). High buffer concentra-
tions are needed in the assays because CO2 is released in the b-decar-
boxylation reaction. The b-decarboxylase activity of the two mutant
enzymes is sensitive to pH; a deviation by 0.5 from the optimum at pH
7.5 decreases the activity by 50% (data not shown). After addition of 0.5
mmol of L-valine as internal standard, 20-ml deproteinized samples of
the reaction mixture were derivatized with 2-fluoro-2,4-dinitrophenyl-
5-L-alanine amide (Marfey’s reagent) and analyzed as described
previously (15, 21).
For the determination of the rates of desulfination of L-cysteine
sulfinate, the enzymes (0.45 mM, subunit concentration) were incubated
with 100 mM L-cysteinesulfinic acid and 50 mM 2-oxoglutarate in 200
mM 4-methylmorpholine (pH 7.5) at 25 °C, and the production of ala-
nine was measured as described above. To check which pathway of
b-elimination the enzymes were following (see Scheme 1), the same
experiments were performed in the presence of 45 units/ml lactate
dehydrogenase and 50 mM NADH to trap any pyruvate produced by
hydrolysis of the ketimine intermediate 9 (see Scheme 1). Transamina-
tion of L-cysteine sulfinate was quantified by the increase in the con-
centration of L-glutamate produced by the reaction of the PMP form of
the enzyme with oxoglutarate.
X-ray Crystallographic Structure Determination—Crystals of AspAT
Y225R/R292K/R386A were grown with the hanging drop technique. A
solution containing 15 mg/ml protein, 2 mM 59-phosphopyridoxyl L-
aspartate (13), and 50 mM 4-methylmorpholine (pH 7.5) was mixed 1:1
with reservoir solution containing 1.98 M ammonium sulfate, 2% (w/v)
polyethylene glycol (Mr 400), and 200 mM 4-methylmorpholine (pH 7.5).
Crystals grew to a maximum size of 0.2 3 0.4 3 1.5 mm in ;4 weeks.
Nucleation and crystal growth proved more problematic than in the
case of wild-type AspAT, probably indicating a less stable conformation
of the protein. As found before for crystals of wild-type and mutant E.
coli AspATs (14, 22), the crystals belong to space group P21 with unit
cell dimensions a 5 88.03 Å, b 5 80.32 Å, c 5 87.82 Å, and b 5 119.85 °.
Diffraction data were collected to a resolution of 2.16 Å, using a
MARresearch imaging plate mounted on a modified Elliott GX20 rotat-
ing copper anode generator. Raw data were processed with MOSFLM
(23). Images were scaled with SCALA and AGROVATA and reduced to
structure factors with TRUNCATE from the CCP4 Program Suite (24).
A total of 170,054 measured reflections were merged together with Rsym
5 0.082 to give rise to the data set of 50,068 independent reflections,
which is 87.7% complete to 2.16-Å resolution. The structure of the
59-phosphopyridoxyl aspartate complex of AspAT Y225R/R292K/R386A
was solved by molecular replacement with the program AMORE (24),
using the refined structure of the open form of the wild-type enzyme
(22) as search model, and refined with TNT (25) to r 5 0.19. The root
mean square deviations of the bond lengths, bond angles, and planes
from the ideal values were 0.011 Å, 1.35°, and 0.01 Å, respectively.
Molecular Dynamics Calculation—The simulations of the quinonoid
intermediates 3 (see Scheme 1) were performed as described previously
(14). The cell multipole method (26) was used instead of a cutoff for the
nonbonded interactions. The modeled structure of the triple-mutant en-
zyme was obtained by the replacement of Arg292 with a lysine residue in
the double-mutant crystal structure. The systems were relaxed by 4000
steps of energy minimization. The amino acid residues and water mole-
cules beyond a distance of 11 Å from the coenzyme-substrate adduct were
kept fixed during the following 100 ps of simulation at 300 K.
RESULTS
L-Aspartate b-Decarboxylase Activity—The introduction of
the additional mutation R292K into AspAT Y225R/R386A did
not affect its L-aspartate b-decarboxylase activity (Fig. 2); the
kcat and Km9 values of the triple- and double-mutant enzymes
are the same (Table I). Two different pathways to produce
L-alanine from L-aspartate are possible, i.e. direct b-decarbox-
ylation of L-aspartate (7 3 8 3 1 in Scheme 1) or b-decarbox-
ylation coupled with transamination (7 3 9 3 5), producing
pyruvate, which, by transamination, may be converted to L-
alanine. To determine the partition ratio of the two pathways,
the consumption of oxalacetate (consumed in the reaction with
the PMP form of the enzyme 5 to produce the PLP form 1 and
L-aspartate) and the production of pyruvate in the presence of
L-aspartate and oxalacetate (conditions as described in the
legend to Fig. 2) were followed in parallel with the b-decarbox-
ylation of L-aspartate (Table II). Both AspAT Y225R/R386A
and AspAT Y225R/R292K/R386A produced pyruvate with a
kcat of only 0.01 s
21, corresponding to a partition ratio (7 3 8
versus 7 3 9) of 8. In the wild-type enzyme, production of
FIG. 1. Stereo view of the active site of the 5*-phosphopyri-
doxyl L-aspartate complexes of AspAT Y225R/R292K/R386A
(thick lines) and wild-type AspAT (thin lines). The asterisks denote
residues from the adjacent subunit. Gly38 and Ile37 were omitted for
clarity. The orientation of the small domain significantly differed in the
two structures (residues 17, 18, 360, 382, and 386; lower right): 59-
phosphopyridoxyl L-aspartate (PPL-Asp) locks wild-type AspAT in the
closed conformation, whereas the triple-mutant stays in the open con-
formation. A water molecule (Wat) is found in the triple-mutant struc-
ture close to the position of a water molecule that, in mitochondrial
AspAT, is assumed to carry out hydrolysis of the ketimine intermediate
(V. N. Malashkevich and J. N. Jansonius, unpublished data).
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pyruvate by far exceeded that of L-alanine. Probably, most of
the L-alanine produced by the wild-type enzyme was formed by
transamination of pyruvate.
Replacement of Arg292 in AspAT Y225R/R386A with a glu-
tamate or valine residue led to 16- and 100-fold decreases in
kcat for b-decarboxylation, respectively (Table I). Arg
292 was
substituted with glutamate to introduce a negative charge that
might destabilize the b-carboxylate group (29, 30) and thus
enhance b-decarboxylation. If the ratio of b-decarboxylase to
transaminase activity is considered rather than the absolute
kcat value, AspAT Y225R/R292E/R386A is indeed a more spe-
cific L-aspartate b-decarboxylase than its counterpart with the
R292K substitution, its b-decarboxylase activity being 100
times higher than its transaminase activity (Table I). Replace-
ment of Arg292 with tyrosine eliminated the positive charge,
whereas the phenolic hydroxy group could still form a hydrogen
bond with the b-carboxylate group of the substrate and thus
maintain the binding function. However, AspAT Y225R/R292Y/
R386A proved to have very low affinity for the substrates and
no measurable b-decarboxylase activity.
Transaminase Activity—The replacement of Arg292 with ly-
sine, glutamate, valine, or tyrosine in AspAT Y225R/R386A led
to a further marked decrease in kcat for transamination (Table
I). However, only with the R292K substitution as the third
mutation was b-decarboxylase activity maintained. The Km
values for dicarboxylic substrates of the single-, double-, and
triple-mutant enzymes are invariably higher than those of the
wild-type enzyme, with the exception of the single Y225R mu-
tation, which has been reported to decrease the Km values for
C4 and C5 dicarboxylic substrates (14, 27, 31, 32). In AspAT
Y225R/R292K/R386A in particular, the Km values for L-aspar-
tate and 2-oxoglutarate are, as in the Y225R/R386A double-
mutant enzyme, seven and four times higher, respectively,
than in the wild-type enzyme.
AspAT Y225R/R292E/R386A was also tested for activity to-
ward L-lysine, L-arginine, and L-ornithine. A very slow
transamination reaction of L-lysine with an initial rate of 0.001
s21 could be detected. Such an effect of a negative charge at
position 292 has been reported previously (33–35). Under the
same conditions, no reaction of L-lysine with the wild-type
enzyme was observed. None of the mutant enzymes showed
any measurable reaction other than transamination toward
D/L-glutamate, D-aspartate, L-tyrosine, or L-serine and their
cognate oxo acids.
Desulfination of L-Cysteine Sulfinate—Wild-type AspAT cat-
alyzed the transamination of L-cysteine sulfinate at a very high
rate. As a side reaction, elimination of sulfinate produced L-
alanine (Table II). Both AspAT Y225R/R386A and AspAT
Y225R/R292K/R386A showed a reaction specificity that was
inverse to that of the wild-type enzyme, desulfination of L-
cysteine sulfinate being by an order of magnitude faster than
its transamination reaction. The double mutation increased
desulfination activity 3-fold and decreased transaminase activ-
ity toward L-cysteine sulfinate by 4 orders of magnitude. The
introduction of the third mutation (R292K) reduced both de-
sulfination and the transamination activity of the double-mu-
tant enzyme by an order of magnitude. Lactate dehydrogenase
plus NADH had no effect on kcat of desulfination by the wild-
type and mutant AspATs, indicating that L-alanine is produced
by direct desulfination of L-cysteine sulfinate rather than
through formation of pyruvate followed by transamination.
Crystal Structure—The 59-phosphopyridoxyl aspartate com-
plex of the triple-mutant enzyme (Y225R/R292K/R386A) was
found in the open conformation (Fig. 1). In the wild-type en-
zyme, binding of dicarboxylic substrates or inhibitors induces
the closed conformation of the enzyme, in which water mole-
cules are excluded from the vicinity of the Schiff base (13). The
open conformation of the triple-mutant enzyme allows water
molecules to enter the active site in the presence of the sub-
strate analog. Lys258, which is responsible in the wild-type
enzyme (13) for the deprotonation at C-a and reprotonation at
C-49 of the coenzyme (Scheme 1), has moved away from its
position near these atoms, where a water molecule is now
found. The amino group of Lys258 is within hydrogen-bonding
distance to Arg225. Lys292 does not interact with the distal
carboxylate group of the aspartate moiety; it forms a hydrogen
bond with Ser296 instead, whereas a water molecule occupies
its original position. The electron density of the aspartate moi-
ety is highly disordered due to the lack of Arg292 and Arg386,
which are key residues for substrate binding in the wild-type
enzyme. Nevertheless, the coenzyme-substrate adduct main-
tains a conformation that allows elimination of the proton at
C-a, the C-a–H bond together with the imine nitrogen staying
in a plane orthogonal to the plane defined by the coenzyme ring
(13, 36).
Molecular Dynamics Simulations—In the simulation of the
external aldimine intermediate based on the crystal structure
of AspAT Y225R/R292K/R386A (Fig. 1), Lys258 did not displace
the intervening water molecule and approach C-a. This situa-
tion most probably is due to a crystal artifact as it would
correspond to a catalytically inactive enzyme. The dynamics
calculations for the quinonoid intermediate of the triple-mu-
tant enzyme were therefore based on the crystal structure of
AspAT Y225R/R386A (14), in which Arg292 had been replaced
with a lysine residue. In this case, Lys258 stayed close enough
to C-a and C-49 for acting as the acid-base group in the tau-
tomerization from aldimine 2 to ketimine 4. In the molecular
dynamics simulation of the quinonoid intermediate of AspAT
Y225R/R292K/R386A, as in those of AspAT Y225R/R386A, a
hydrogen bond between Arg225 and the imine nitrogen atom is
formed (Fig. 3). During the simulation, this hydrogen bond
exists only 5% of the time in AspAT Y225R, whereas it is
present 35% of the time in the double- and triple-mutant en-
zymes. In all AspATs containing the Y225R mutation, the
proximity of the positively charged guanidinium group re-
pulses the protonated Lys258. Its longer distance from C-49 of
the coenzyme hinders reprotonation of that atom and might
underlie the decrease in transaminase activity. In the simu-
lated structures of the quinonoid intermediate of the wild-type
enzyme, Lys258 remains positioned above the imine nitrogen at
almost equal distance from C-a and C-49.
FIG. 2. b-Decarboxylation of L-aspartate catalyzed by AspAT
Y225R/R292K/R386A (l), AspAT Y225R/R386A (), and wild-type
AspAT (f). Enzymes (0.45 mM, subunit concentration) were incubated
with 200 mM L-aspartate and 8 mM oxalacetate in 250 mM 4-methyl-
morpholine (pH 7.5) at 25 °C. For details of the detection of L-alanine,
see “Experimental Procedures.”
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DISCUSSION
The triple mutation Y225R/R292K/R386A brings about a
switch in the reaction specificity of E. coli AspAT. The conjoint
R386A and Y225R substitutions enhance the very low L-aspar-
tate b-decarboxylase activity of the wild-type enzyme and de-
crease transaminase activity. Measurements of the activity of
the pertinent single- and double-mutant enzymes other than
Y225R/R386A confirmed that the increase in b-decarboxylase
activity strictly depends on the combined effects of the R386A
and Y225R substitutions (Table I). This double mutation
amounts to a shift of an arginine residue from position 386 to
position 225. The third mutation, replacement of Arg292 with
lysine, selectively lowers transaminase activity to one-eighth of
b-decarboxylase activity. Together, the three mutations in-
crease the ratio of b-decarboxylase to transaminase activity
.25 million-fold. Molecular dynamics simulations of the wild-
type and triple-mutant enzymes based on crystal structures
suggested, as previously for the double-mutant enzyme, that
Arg225 makes, in addition to the hydrogen bond with O-39 of the
coenzyme, a second hydrogen bond with the imine nitrogen of
the quinonoid intermediate. In the wild-type enzyme, the imine
nitrogen is not engaged in a hydrogen bond, whereas O-39
forms a hydrogen bond with Tyr225. The single Y225R mutation
is apparently not sufficient to give rise to the formation of a
hydrogen bond from Arg225 to the imine nitrogen atom (14).
The mutation has been found to decrease the pKa of the inter-
nal aldimine from 6.8 in the wild-type enzyme to 6.2 due to a
strong hydrogen bond of Arg225 with O-39 (27), which pulls
electrons out of the p-system extending from the pyridine ring
of PLP to the aldimine bond. The imine nitrogen might thus
become a too weak nucleophile to accept a hydrogen bond from
Arg225. The replacement of Arg386 by an alanine residue has
TABLE I
Kinetic parameters for b-decarboxylase and transaminase activities of wild-type and mutant AspATs
The b-decarboxylase assay was carried out in 200 mM L-aspartate plus 8 mM oxalacetate in 250 mM 4-methylmorpholine (pH 7.5). Transaminasc
activity was measured in the presence of 20 mM L-aspartate plus 20 mM 2-oxoglutarate in 50 mM 4-methylmorpholine (pH 7.5) for the wild-type
enzyme and 100 mM L-aspartate plus 50 mM 2-oxoglutarate in 100 mM 4-methylmorpholine (pH 7.5) for the mutant enzymes. Because the
transaminase activity of AspAT Y225R/R292E/R386A was too low to be analyzed with a coupled assay, the transformation of the PLP form of the
enzyme into the PMP form upon addition of 100 mM L-aspartate was followed spectrophotometrically instead. The disappearance of the PLP form
and the appearance of the PMP form of the enzyme were recorded at 360 and 330 nm, respectively. All reactions were run at 25 °C. One
double-mutant enzyme, AspAT Y225R/R292K, was not expressible in E. coli TY103. In the cell crude extract, no soluble enzyme could be detected
on SDS-polyacrylamide gel after silver staining.
AspAT b-Decarboxylationkcat
Transamination
kcat
Km(Asp)
9 Km(OG)
9a
s21 s21 mM mM
Y225R/R292K/R386A 0.08 0.01 8.8 0.8
Y225R/R292E/R386A 0.005 5 3 1025 ND ND
Y225R/R292V/R386A 8 3 1024 0.051 6.8 0.36
Y225R/R292Y/R386A BD 0.025 200 14
Y225R/R386A 0.08 0.19 8.3 0.8
R292K/R386A 7.5 3 1024 0.094 14 0.25
Y225R BD 0.45 0.83b 0.36b
R292K 1.8 3 1023 0.5c 14c 2.7c
R386A BD 0.33 15 5
Wild-type 6 3 1025 d 180 1.2 0.2
a OG, 2-oxoglutarate; ND, not determined; BD, below detection limit.
b From Ref. 27.
c From Ref. 15.
d Most of the L-alanine produced in the presence of the wild-type enzyme is probably due to transamination of pyruvate formed by b-decarbox-
ylation of oxalacetate.
SCHEME 1. Reaction pathways of enzymic transamination and b-replacement.
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been reported previously to disrupt the hydrogen-bonding net-
work Arg386 3 Asn194 3 O-39 (37) and thus to allow the
electrons of O-39 to flow into the p-system. As a consequence,
the imine nitrogen in the double-mutant enzyme might engage
in a hydrogen bond with Arg225. A similar effect of the Y225R/
R386A mutations might be operative in the quinonoid interme-
diate (14). The O-39–Arg225 and imine nitrogen–Arg225 hydro-
gen bonds may be assumed to reinforce the electron sink
capacity of the p-system of imine and the cofactor pyridine ring
to such an extent that, even after deprotonation at C-a, it
remains effective enough to stabilize carbanion 6 (Scheme 1),
produced by b-decarboxylation. Other factors that might favor
b-decarboxylation, such as the angle of the C-b–C-g bond rel-
ative to the coenzyme-imine p-system (36) and negative elec-
trostatic potentials around the b-carboxylate group that might
promote electron delocalization (38), could not be verified; nei-
ther the bond angles nor the electrostatic potentials in AspAT
Y225R/R292K/R386A were significantly different from those in
the wild-type enzyme.
The decrease in transaminase activity observed in both Asp-
AT Y225R/R386A and AspAT Y225R/R292K/R386A might be
due to the repulsion between Lys258 and Arg225 impairing the
reprotonation of the quinonoid intermediate 3 at C-49. A pos-
sible explanation for the further decrease brought about by the
third mutation (R292K) is provided by the recent crystallo-
graphic analysis of three reaction intermediates of the wild-
type enzyme 7 that has shown a water molecule to be posi-
tioned near C-a in the ketimine intermediate 4; this water
molecule is supposed to effect the hydrolysis of the ketimine.2
Its nucleophilicity might be enhanced by a hydrogen-bonding
network comprising Tyr70, Lys258, and Gly38. The effect of
these interactions is maximal if the active site is in the closed
conformation because the rotation of the small domain brings
Gly38 into a position where it can take part in this network. The
wild-type enzyme assumes the closed conformation on binding
a dicarboxylic amino or oxo acid to the two active-site arginine
residues, Arg292 and Arg386. By interacting with the substrate,
the two arginines are pulled toward each other, inducing the
domain movement (13, 22, 39). In AspAT Y225R/R292K/
R386A, the mutation of both arginine residues prevents the
enzyme from adopting a closed conformation (Fig. 1), with the
consequence that the water molecule might not be reactive
enough to attack C-a. In AspAT Y225R/R386A, with only one
substrate-binding arginine missing, the syncatalytic closure of
the active-site cleft is partially retained (14).
The importance of the domain movement for the reactivity of
the catalytic water molecule in the hydrolysis of the ketimine
intermediate might also explain the reaction pathway of both
b-decarboxylation and b-desulfination. The amino acid L-cys-
teine sulfinate is a dianion like aspartate and is a physiologic
substrate for AspAT (40, 41). The reaction specificity of both
AspAT Y225R/R386A and AspAT Y225R/R292K/R386A toward
L-cysteine sulfinate is inverse to that of the wild-type enzyme.
The mutant enzymes desulfinate this substrate faster than
they undergo the transamination reaction with it. Neverthe-
less, similar to the wild-type enzyme and in analogy to the
b-decarboxylation reaction with aspartate, they preferentially
reprotonate carbanion 7 (Scheme 1) at C-a rather than C-49
and produce L-alanine (7 3 8 3 1) rather than pyruvate (7 3
93 5). Conceivably, upon loss of the negatively charged b-sub-
stituent, the active site assumes the open conformation. Thus,
the frequency of ketimine hydrolysis is decreased, and the
partition ratio is shifted in favor of reprotonation at C-a, re-
sulting in the production of L-alanine.
The starting point of this work was a study of the molecular
evolution of B6 enzymes (11). Within a given family, in partic-
ular in the large a-family, a clear temporal sequence of differ-
ent phases in the functional specialization is evident. The com-
mon ancestor enzyme, apparently an unspecific all-rounder
catalyst, first diverged into reaction-specific protoenzymes,
which then diverged further and acquired substrate specificity.
The last phase for most B6 enzymes was the neutral evolution
concomitant with speciation.3 The conjoint substitution of
three active-site residues that converted AspAT into an L-
aspartate b-decarboxylase seems to simulate the processes
that, in the first phase of molecular evolution, might have led to
reaction-specific B6 enzymes by accelerating the specific reac-
tion and suppressing potential side reactions. To the best of our
knowledge, such a clear change in reaction specificity with a
remarkably high new activity (kcat 5 0.08 s
21) has as yet only
been reported for papain that was converted into a peptide-
2 V. N. Malashkevich and J. N. Jansonius, unpublished data.
3 Mehta, P. K., and Christen, P. (2000) Adv. Enzymol. Relat. Areas
Mol. Biol., in press.
TABLE II
Comparison of kcat values for b-decarboxylation and transamination with those of b-desulfination
Desulfination activity was determined by incubating 0.45 mM enzyme (subunit concentration) with 100 mM L-cysteine sulfinate and 50 mM
2-oxoglutarate in 200 mM 4-methylmorpholine (pH 7.5) at 25 °C. Transamination of L-cysteine sulfinate was measured by the amount of
L-glutamate produced in the regeneration of the PLP form from the PMP form of the enzyme (for details, see “Experimental Procedures”).
AspAT
kcat
L-Aspartate L-Cysteine sulfinate
b-Decarboxylationa Transaminationa Pyruvate production b-Desulfination Transamination
s21
Y225R/R292K/R386A 0.08 0.01 0.01 0.02 0.002
Y225R/R386A 0.08 0.19 0.01 0.165 0.024
Wild-type 6 3 1025 180 0.0016 0.05 512b
a Values are taken from Table I.
b From Ref. 28.
FIG. 3. Hydrogen bonds in the active sites of the quinonoid
intermediate 3 of wild-type and mutant AspATs during the mo-
lecular dynamics simulation. The substrate is L-aspartate. The mod-
els represent the averaged structures of the last 10 ps of 100-ps simu-
lations. The numbers indicate the fraction of time during which the
hydrogen bond exists during the simulation. Numbers .1 are the sums
for all possible hydrogen bonds of the same atom.
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nitrile hydratase by a single amino acid substitution at the
active site (10).
Two features of the procedure used in this study for changing
the reaction specificity might be generally applicable to B6
enzymes and perhaps certain other enzymes as well. 1) The
double mutation Y225R/R386A shifts an arginine residue from
its wild-type position to another position in its immediate vi-
cinity. Such charge-shifting double mutations may be expected
not to disturb greatly the topochemistry of the active site, but
to alter the electron repartition at the reaction center. 2) Argi-
nine residues are the preferred binding groups for anionic
substrates in enzymes (15). Their conservative substitution by
lysine, which is slightly shorter and engages in fewer hydrogen
bonds, may be expected to change the mode of binding of the
substrate.
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